The U.S. Supreme Court asked the Obama administration this week for its position on an appeal filed by generic drug manufacturers who argue that federal law provides them complete immunity from state lawsuits, even when their products cause serious harm to patients.
Seeded on Thu May 27, 2010 1:18 PM EDT
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (0)
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



